多池化学交换饱和转移磁共振成像作为分子特异性生物标志物:检测新生儿缺氧缺血性脑病的组织病理学改变
前瞻性研究纳入20例新生儿缺氧缺血性脑病(HIE)患儿与42例年龄匹配对照,行3.0-T多池化学交换饱和转移(CEST)MRI,按新生儿图谱分区分析尾状核、壳核、丘脑、苍白球、杏仁核和海马信号。HIE组多个脑区酰胺质子转移、核奥弗豪泽增强和磁化转移信号较对照显著降低(均P<0.05),中重度HIE较轻型进一步降低;左侧海马核奥弗豪泽增强鉴别严重程度的AUC为0.96,多区域整合模型分期AUC为1.00。
要点
- 多池CEST MRI可无创反映新生儿HIE的代谢-病理改变,左侧海马核奥弗豪泽增强对严重程度分层AUC达0.96。
- 常规酰胺质子转移加权成像未见显著变化,因酰胺质子转移信号降低被核奥弗豪泽增强同步降低所抵消,提示需多池分析。
- 中重度HIE较轻型在右侧丘脑酰胺质子转移、双侧海马核奥弗豪泽增强及左侧海马/丘脑磁化转移信号上进一步降低(均P<0.05)。
核心结论
- 多池CEST MRI能有效捕捉新生儿HIE的组织病理学改变,左侧海马核奥弗豪泽增强可作为严重程度分层的精确生物标志物;酰胺质子转移、核奥弗豪泽增强与磁化转移信号的联合动态变化为代谢-病理相关性提供了无创洞察,并突显其在早期诊断和靶向治疗监测方面的转化潜力。
研究设计与样本
- 前瞻性研究,纳入20例HIE新生儿和42例年龄匹配对照,行3.0-T CEST MRI,数据空间标准化至新生儿图谱后进行尾状核、壳核、丘脑、苍白球、杏仁核、海马的区域特异性分析;组间CEST信号差异采用Wilcoxon检验,诊断效能通过受试者工作特征分析评估。
关键影像表现/征象
- 与对照相比,HIE新生儿酰胺质子转移信号在双侧壳核、右侧海马/苍白球/杏仁核、左侧丘脑/尾状核显著降低(均P<0.05)。
- HIE新生儿核奥弗豪泽增强信号在左侧丘脑/尾状核/壳核显著降低,磁化转移信号在双侧丘脑/苍白球/壳核及左侧尾状核显著降低(均P<0.05)。
- 亚组分析显示中重度HIE较轻型病例右侧丘脑酰胺质子转移进一步降低、双侧海马核奥弗豪泽增强降低、左侧海马/丘脑磁化转移降低(均P<0.05)。
- 常规酰胺质子转移加权成像未见显著变化,因酰胺质子转移信号降低被核奥弗豪泽增强同步降低所抵消。
诊断标准与关键数值
- 左侧海马核奥弗豪泽增强区分严重程度的AUC=0.96。
- 多区域整合模型分期准确性的AUC=1.00。
- 组间CEST信号比较采用Wilcoxon检验,显著性阈值P<0.05。
临床应用与阅片要点
- 阅片时可关注多池CEST参数(酰胺质子转移、核奥弗豪泽增强、磁化转移)在双侧壳核、丘脑、苍白球、海马、尾状核及杏仁核的区域性信号降低。
- 评估严重程度时可参考左侧海马核奥弗豪泽增强及多区域整合模型,但需注意本研究为前瞻性小样本,结论尚需进一步验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Neonatal hypoxic-ischemic encephalopathy (HIE) diagnosis is confounded by heterogeneous neural injury and metabolic dysfunction. Multi-pool chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) uniquely quantifies amide proton transfer, nuclear Overhauser enhancement, and magnetization transfer signals, providing multi-parametric assessment of HIE pathophysiology.
OBJECTIVE: To investigate whether multi-pool CEST MRI can serve as a molecular-specific biomarker for histopathological alterations in HIE and assess its efficacy in grading disease severity.
MATERIALS AND METHODS: This prospective study included 20 neonates with HIE and 42 age-matched controls undergoing 3.0-T CEST MRI. Imaging data were spatially normalized to a neonatal atlas for region-specific analysis (caudate, putamen, thalamus, pallidum, amygdala, hippocampus). Group differences in CEST signals (amide proton transfer, nuclear Overhauser enhancement, magnetization transfer) were analyzed via Wilcoxon tests, with diagnostic performance evaluated through receiver operating characteristic analysis.
RESULTS: Compared to controls, HIE neonates showed significant reductions in amide proton transfer (bilateral putamen, right hippocampus/pallidum/amygdala, left thalamus/caudate), nuclear Overhauser enhancement (left thalamus/caudate/putamen), and magnetization transfer signals (bilateral thalamus/pallidum/putamen, left caudate; all P<0.05). Subgroup analysis revealed progressive metabolic decline: moderate-to-severe HIE exhibited further amide proton transfer reduction in the right thalamus, nuclear Overhauser enhancement decreases in bilateral hippocampus, and magnetization transfer decreases in left hippocampus/thalamus compared to mild cases (all P<0.05). Notably, conventional amide proton transfer-weighted imaging showed no significant changes, as the reduction in amide proton transfer signal was offset by a concurrent decrease in the nuclear Overhauser enhancement, highlighting the superiority of multi-pool analysis. Left hippocampal nuclear Overhauser enhancement demonstrated exceptional severity discrimination (area under curve (AUC)=0.96), while a multi-region integrated model achieved perfect staging accuracy (AUC=1.00).
CONCLUSION: Multi-pool CEST MRI effectively captures histopathological changes in neonatal HIE, with left hippocampal nuclear Overhauser enhancement emerging as a precise biomarker for severity stratification. The combined dynamics of amide proton transfer, nuclear Overhauser enhancement, and magnetization transfer signals provide noninvasive insights into metabolic-pathological correlations, highlighting its transformative potential for early diagnosis and targeted therapeutic monitoring.
引用
- Zhuang X, Wu Y, Jiang G, et al. Multi-pool chemical exchange saturation transfer magnetic resonance imaging as a molecular-specific biomarker: detecting histopathological changes in neonatal hypoxic-ischemic encephalopathy. Pediatr Radiol. 2025. PMID: 41123647. doi:10.1007/s00247-025-06417-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。